Bulletin from Annual General Meeting of Diamyd Medical AB
The Annual General Meeting of Diamyd Medical AB (publ) was held on November 15, 2018. The Company's income statement and balance sheet were adopted, and the Board members and the Chief Executive Officer were discharged from liability for the fiscal year 2017/2018. The Annual General Meeting approved the Board's proposal that no dividend be paid for the fiscal year 2017/2018. Erik Nerpin was re-elected as Chairman of the Board and Anders Essen-Möller, Maria-Teresa Essen-Möller and Torbjörn Bäckström were re-elected to the Board. Mark A. Atkinson was elected as new Board member.